In the drug sensitivity analysis, 112 drugs (including WZ3105; <i>p</i> < 0.05) showed differential responses, and UNC93B1 showed high positive expression in BLCA tissues (positive cell proportion > 75%). The gene discussed is UNC93B1; the disease is bladder transitional cell carcinoma.